#United States #Santa Clara #Verix #Tovana #vQL

Verix's Patent for Dynamic Code Technology

Verix, a pioneer in life sciences commercial optimization, has achieved a significant milestone by securing a patent from the United States Patent and Trademark Office (USPTO) for its innovative Verix Query Language (vQL). This proprietary dynamic code technology is integral to the functionality of Verix's flagship Tovana™ platform, designed specifically to enhance intelligent automation and streamline operations for life sciences companies.

The Essence of vQL Technology

At the forefront of this advancement is vQL, a technology crafted for accessibility and efficiency. It allows users with a basic understanding of SQL to harness the power of automation, eliminating the need for extensive programming knowledge. This breakthrough enables Tovana to conduct adaptive, context-sensitive data operations. By doing so, it dramatically improves how commercial teams access crucial insights, automate workflows, and implement new analytical approaches with ease.

Traditional SQL systems are static by nature, which often constrains flexibility and automation within enterprise data environments. In contrast, vQL introduces a dynamic runtime logic that empowers data queries and applications to automatically adjust based on various business contexts— such as user roles, behaviors, and real-time data changes.
This innovation transforms SQL’s rigid foundations into a sophisticated automation layer, fostering agility in operations for data-driven teams.

A Game Changer in Business Intelligence

The patenting of vQL underlines Verix's dedication to relentless innovation. Doron Aspitz, CEO of Verix, stated, "This dynamic code technology is a cornerstone of how Tovana operates— automating complex processes while adapting in real-time. It enables commercial teams to concentrate on decision-making rather than data management, marking a significant advancement in intelligent automation for the life sciences sector."

vQL is seamlessly integrated throughout the Tovana Commercial Optimization Platform, facilitating various functions, from data pipeline creation and modeling to real-time analytics and visualization. The result is accelerated deployment of predictive workflows, reduced operational complexities, and enhanced operational agility for pharmaceutical organizations globally.

Incorporating dynamic code automation supports standard SQL integrations without necessitating extensive infrastructure changes. Firms can enjoy the advantages of enhanced automation while demanding only a foundational understanding of SQL from their teams. This development not only maximizes efficiency but also propels innovation across different commercial operations.

About Verix and its Vision

Verix positions itself as the leading provider of Tovana, an advanced Commercial Optimization Platform tailored for organizations in the life sciences sector. The Tovana platform leverages advanced artificial intelligence, dynamic code automation, and in-depth industry expertise to optimize critical areas like healthcare professional targeting, precision forecasting, omnichannel benchmarks, and patient discovery processes.

Through the convergence of sophisticated data science and adaptive automation, Verix is empowering pharmaceutical companies worldwide to enhance brand performance with accuracy, speed, and confidence.

In this dynamic landscape, the innovative strides taken by Verix signify a future where data handling in the life sciences sector is not just efficient but also simplified and accessible to teams across various skill levels. The issuance of the patent for vQL confirms that Verix stands at the forefront of transforming the industry's approach to commercial optimization and intelligent automation.